Demand for nurse practitioners exceeded other specialty providers, report finds
For the third year in a row, demand for nurses surpassed demand for other specialties, according to a report from staffing firm AMN Healthcare.
Microsoft-Epic partnership yields EHR cloud solution
Mount Sinai Health System is the first provider to implement Azure Large Instances, which scales database capacity to the level needed for health record workloads.
Will the Biden administration’s short-term plan rule increase the uninsured rate?
Free-market advocates argue proposed restrictions on short-term plans will leave consumers without coverage. Health policy researchers aren’t so sure.
PE healthcare deals dropped to years-low levels in Q2
The amount of private equity deals decreased 23.7% compared to the first quarter this year. However, Q2 deal volume was still 12.3% higher than the average quarterly deal count pre-pandemic, according to a report from PitchBook.
Rebuilding trust to empower the future of healthcare
See how the latest in AI can move the conversation back to the forefront with clinical documentation that writes itself—all within the EHR—so clinicians can focus on their patients.
DOJ hits UnitedHealth, Amedisys with second request over $3.3B deal
The request for more information pushes back the timeline of the merger as regulators take a more active stance in healthcare M&A oversight.
Cano Health exploring sale, lays off 700 employees
The value-based primary care chain posted a net loss of $270.7 million in the second quarter, nearly 19 times larger than its $14.6 million loss in the prior-year period.
5 predictions for private equity in healthcare
Grant Thornton principal Lisa Walkush explains why healthcare remains one of the most attractive options for private equity firms.
HHS pledges more than $100M to grow nursing workforce
The investment aims to reduce “bottlenecks in nurse training” that stakeholders say hamper recruitment efforts.
Doximity slashes 10% of workforce amid post-COVID pressures
CEO Jeff Tangney attributed the company’s slowdown to “post-COVID upsell weakness,” while also reducing Doximity’s revenue guidance for fiscal year 2024.